Mohs Surgery for Sebaceous Carcinoma

Sebaceous carcinoma is a rare, aggressive cancer of the skin’s oil glands, most often found on or near the eyelids. Complete removal with verified margins is the priority, and Mohs micrographic surgery is frequently the tool for the job.
Book a Consultation:

About Mohs Surgery for Sebaceous Carcinoma:

On the eyelid, every millimeter of tissue affects how the eye closes, blinks, and protects itself—and that’s exactly where sebaceous carcinoma likes to appear. At Charleston Dermatology, our surgeons use Mohs surgery for sebaceous carcinoma to confirm complete removal while preserving as much healthy tissue as possible.

This tumor can spread within the skin in scattered, skip-like patterns, making microscopic margin control especially valuable. Because sebaceous carcinoma can involve lymph nodes and is occasionally linked to Muir-Torre syndrome, your plan may include lymph node evaluation, genetic screening discussion, and coordination with ophthalmology and oncology.

Treated early and thoroughly, outcomes are good—and prompt evaluation of any persistent eyelid lesion is the key. Schedule a consultation without delay.

Frequently Asked Questions

Two reasons: location and behavior. Most cases arise on the eyelids, where reconstruction after removal requires precision and often teamwork with oculoplastic colleagues. And the tumor can spread within the skin in discontinuous patches, so margin-controlled techniques like Mohs reduce the chance of leaving cancer behind.

Your provider may recommend lymph node examination or imaging, since sebaceous carcinoma can spread to regional nodes. Because some cases occur as part of Muir-Torre syndrome — an inherited condition linked to colon and other internal cancers — screening and family history review are part of thorough care.

Detected and removed early, sebaceous carcinoma has a good prognosis, and margin-controlled surgery lowers recurrence risk meaningfully. Follow-up is close in the first years — typically exams every few months initially — because early detection of any recurrence or nodal involvement makes re-treatment far more effective.

Our Specialists

Adam Sperduto, MD
Roger Sullivan, MD
Lee Yarbrough, MD
Ashley Allen, MD
Megan Hohenberger, MD